Concepedia

Publication | Open Access

Analysis of left ventricular mass in untreated men and in men treated with agalsidase-β: data from the Fabry Registry

DOIFull Paper Access

92

Citations

26

References

2013

Year

Dominique P. Germain, Frank Weidemann, Ademola K. Abiose, Manesh R. Patel, Marta Cizmarik, J. Alexander Cole, Dana Beitner‐Johnson, Karelle Bénistan, Gustavo Cabrera, Joel Charrow,
Genetics in Medicine

Abstract

Agalsidase-β treatment for ≥2 years may improve or stabilize left-ventricular mass in men with Fabry disease. Further investigations may determine whether early intervention and stabilization of LVM are correlated with clinical outcomes.

References

YearCitations

Page 1